U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
184831184831A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese SubjectsCompletedNo Results AvailableObesityDrug: CP-945,598|Drug: sibutraminehttps://ClinicalTrials.gov/show/NCT00134199
184832184832Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) CancerCompletedNo Results AvailableCarcinoma, Renal Cell|Urogenital Neoplasms|Urologic Neoplasms|Kidney NeoplasmsDrug: motexafin gadoliniumhttps://ClinicalTrials.gov/show/NCT00134186
184833184833A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart DiseaseCompletedNo Results AvailableCoronary Disease|Coronary Arteriosclerosis|HyperlipidemiaDrug: torcetrapib/atorvastatin|Drug: atorvastatinhttps://ClinicalTrials.gov/show/NCT00134173
184834184834OlmeSartan and Calcium Antagonists Randomized (OSCAR) StudyCompletedNo Results AvailableHypertension|Cardiovascular DiseasesDrug: Olmesartan medoxomil|Drug: Calcium channel blockers (amlodipine, azelnidipine)https://ClinicalTrials.gov/show/NCT00134160
184835184835A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose ControlCompletedNo Results AvailableDiabetes MellitusDrug: Inhaled Insulinhttps://ClinicalTrials.gov/show/NCT00134147
184836184836Efficacy and Safety of Efalizumab in the Treatment of Moderate-Severe Hydradenitis SuppurativaCompletedNo Results AvailableHidradenitis SuppurativaDrug: efalizumabhttps://ClinicalTrials.gov/show/NCT00134134
184837184837Clinical Benefit of Cognitive Behaviour Therapy (CBT) for Insomnia in Cancer PatientsActive, not recruitingNo Results AvailableInsomnia|CancerBehavioral: Cognitive Behaviour Therapyhttps://ClinicalTrials.gov/show/NCT00134108
184838184838S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach CancerActive, not recruitingNo Results AvailableGastric CancerDrug: irinotecan hydrochloride|Drug: tegafur-gimeracil-oteracil potassium|Procedure: adjuvant therapy|Procedure: conventional surgery|Procedure: neoadjuvant therapyhttps://ClinicalTrials.gov/show/NCT00134095
184839184839Rituximab and Cyclophosphamide Followed by Vaccine Therapy in Treating Patients With Relapsed Hodgkin LymphomaActive, not recruitingNo Results AvailableLymphomaBiological: Hodgkin's antigens-GM-CSF-expressing cell vaccine|Biological: filgrastim|Biological: rituximab|Drug: cyclophosphamidehttps://ClinicalTrials.gov/show/NCT00134082
184840184840Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal CancerCompletedNo Results AvailableRecurrent Colon Cancer|Recurrent Rectal Cancer|Stage III Colon Cancer|Stage III Rectal Cancer|Stage IV Colon Cancer|Stage IV Rectal CancerDrug: sorafenib tosylate|Drug: cetuximab|Drug: irinotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00134069
184841184841S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone TherapyActive, not recruitingNo Results AvailableMetastatic Cancer|Prostate CancerDrug: atrasentan hydrochloride|Drug: docetaxel|Drug: prednisone|Other: placebohttps://ClinicalTrials.gov/show/NCT00134056
184842184842Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid CancerCompletedHas ResultsInsular Thyroid Cancer|Recurrent Thyroid Cancer|Stage II Follicular Thyroid Cancer|Stage II Papillary Thyroid Cancer|Stage IV Follicular Thyroid Cancer|Stage IV Papillary Thyroid Cancer|Thyroid Gland Medullary CarcinomaDrug: vorinostathttps://ClinicalTrials.gov/show/NCT00134043
184843184843Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With OsteosarcomaActive, not recruitingNo Results AvailableLocalized Osteosarcoma|Metastatic OsteosarcomaDrug: doxorubicin hydrochloride|Drug: cisplatin|Drug: methotrexate|Procedure: therapeutic conventional surgery|Biological: peginterferon alfa-2b|Drug: ifosfamide|Drug: etoposide|Procedure: quality-of-life assessment|Other: questionnaire administrationhttps://ClinicalTrials.gov/show/NCT00134030
184844184844Combination Chemotherapy, Tacrolimus, and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant For Hematologic CancerActive, not recruitingNo Results AvailableChronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic SyndromesDrug: busulfan|Drug: cyclophosphamide|Drug: mycophenolate mofetil|Drug: tacrolimus|Procedure: allogeneic bone marrow transplantation|Procedure: bone marrow ablation with stem cell supporthttps://ClinicalTrials.gov/show/NCT00134017
184845184845Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic CancerCompletedHas ResultsChronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic SyndromesDrug: cyclophosphamide|Drug: fludarabine phosphate|Drug: mycophenolate mofetil|Drug: tacrolimus|Procedure: allogeneic bone marrow transplantation|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00134004
184846184846Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or LeukemiaCompletedNo Results AvailableLeukemia|LymphomaBiological: filgrastim|Biological: pegfilgrastim|Biological: rituximab|Drug: cyclophosphamide|Drug: cytarabine|Drug: leucovorin calcium|Drug: methotrexate|Drug: prednisone|Drug: therapeutic hydrocortisone|Drug: vincristine sulfatehttps://ClinicalTrials.gov/show/NCT00133991
184847184847Trial of Glutamine and Antioxidant Supplementation in Critically Ill PatientsCompletedHas ResultsCritical Illness|Sepsis|Multiple Organ FailureOther: Glutamine|Other: Antioxidants|Other: Glutamine + Antioxidants|Other: Placebohttps://ClinicalTrials.gov/show/NCT00133978
184848184848Psychosocial Support for Cancer PatientsCompletedNo Results AvailableCancerBehavioral: Dignity Psychotherapy|Behavioral: Supportive Psychotherapy|Behavioral: Standard Palliative Carehttps://ClinicalTrials.gov/show/NCT00133965
184849184849Effect of Ruboxistaurin on Clinically Significant Macular EdemaCompletedNo Results AvailableDiabetic Macular EdemaDrug: Ruboxistaurin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00133952
184850184850Proportional Ventilation and Ventilatory SynchronismRecruitingNo Results AvailableMechanical VentilationProcedure: Mechanical ventilationhttps://ClinicalTrials.gov/show/NCT00133939
184851184851Prevention of Pre-Term Birth by Treatment of Periodontal DiseaseRecruitingNo Results AvailablePeriodontal Diseases|Premature Birth|Pre-EclampsiaProcedure: Treatment of periodontal diseasehttps://ClinicalTrials.gov/show/NCT00133926
184852184852Circulating Tumor Cells in Patients With Metastatic Colorectal CancerActive, not recruitingNo Results AvailableColorectal Cancer|Neoplasm MetastasisProcedure: Phlebotomyhttps://ClinicalTrials.gov/show/NCT00133913
184853184853Circulating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving ChemotherapyActive, not recruitingNo Results AvailableHormone Refractory Prostate Cancer|Prostate CancerProcedure: Phlebotomyhttps://ClinicalTrials.gov/show/NCT00133900
184854184854TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant RecipientsCompletedNo Results AvailableSkin Cancer|Kidney TransplantationDrug: rapamycin|Drug: ciclosporine|Drug: tacrolimushttps://ClinicalTrials.gov/show/NCT00133887
184855184855Topical SB-275833 Ointment, 1% For The Treatment Of ImpetigoCompletedNo Results AvailableImpetigo|Skin Infections, BacterialDrug: SB-275833 ointment, 1%https://ClinicalTrials.gov/show/NCT00133874
184856184856Botulinum Toxin Efficiency on Spasticity of Rectus Femoris and Semitendinosus Muscles as Functional Agonist and Antagonist MusclesCompletedNo Results AvailableCerebral PalsyDrug: Botulinum toxinhttps://ClinicalTrials.gov/show/NCT00133861
184857184857Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo OintmentCompletedNo Results AvailableImpetigoDrug: SB-275833 ointment, 1%https://ClinicalTrials.gov/show/NCT00133848
184858184858Comparison of Extracorporeal Shock Wave Lithotripsy (ESWL) Alone and ESWL Plus Endoscopy for Painful Chronic PancreatitisCompletedNo Results AvailablePancreatitisProcedure: Extracorporeal shock wave lithotripsy|Procedure: Endoscopic drainage of the main pancreatic ducthttps://ClinicalTrials.gov/show/NCT00133835
184859184859Civilian Post-Traumatic Stress Disorder Risperidone Clinical TrialCompletedNo Results AvailablePost-Traumatic Stress DisordersDrug: Sertraline and Risperidonehttps://ClinicalTrials.gov/show/NCT00133822
184860184860Islet Transplantation in Type 1 Diabetics Using the Edmonton Protocol of Steroid Free ImmunosuppressionCompletedNo Results AvailableDiabetes Mellitus, Type 1Drug: Transplantation of Human Isletshttps://ClinicalTrials.gov/show/NCT00133809

* Görseller ve İçerik tekif hakkına sahip olabilir